ascopubs.org8d
Effects of loneliness on healthcare utilization and medical expenditures in US cancer survivors.
Enhancing screening for nutritional causes of anemia in hospitalized patients with cancer.
ascopubs.org8d
Optimizing access to care for new patients with cancer discharged from an observation unit.
Understanding the impact of historical redlining on prostate cancer care quality and treatment patterns and the association with modern metrics of disparity. Time interval for new patients to acquire ...
ascopubs.org8d
Health-related quality of life of Canadian patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.
Real-world outcomes among patients with advanced EGFRm NSCLC previously treated with osimertinib and platinum-based chemotherapy. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care ...
ascopubs.org4d
Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org5d
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis: One Decade Later
In 2012, the National Academies of Sciences, Engineering, and Medicine convened a committee charged with addressing the quality of cancer care in the United States and providing recommendations to ...
ascopubs.org6d
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma Using pooled ...
ascopubs.org5d
Stockholm3 in a Multiethnic Cohort: Optimizing Prostate Cancer Screening to Reduce Harm and Improve Equity
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 In the article that ...
ascopubs.org7d
Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
When You Get to the Fork in the Road, Take It: The Challenges in Managing Patients With Advanced Prostate Cancer A multi-institution retrospective study of patients with mTNBC treated with SG from ...
ascopubs.org8d
Food for Cancer Health Equity: The impact of a culturally tailored food voucher intervention on food insecurity among Latinx patients with cancer.
A community health worker–led intervention to improve patient knowledge and receipt of precision medicine: Updated ALCANCE randomized clinical trial findings. This is an ASCO Meeting Abstract from the ...
ascopubs.org6d
State of Geographic Access to Cancer Treatment Trials in the United States: Are Studies Located Where Patients Live?
In this study, we describe the geographic distribution of US cancer treatment trials to identify disparities and opportunities for targeted improvements in access to research for people with cancer.
ascopubs.org5d
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005 The study cohort consisted ...
ascopubs.org4d
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...